abstract |
The present invention relates to compounds useful for treating CFTR mediated diseases, such as cystic fibrosis, such as (R) -1- (2,2-difluorobenzo [d] [1,3] dioxol- (1- (2,3-dihydroxypropyl) -6-fluoro-2- (1 -hydroxy-2-methylpropan-2-yl) -lH- indol-5-yl) cyclopropanecarboxamide (Compound 1). |